LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.42 | 17.25 | 1977 | 3895 | 0.5075 | 0.8338 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.39 | 17.25 | 1 | 4141 | 0.0002 | -0.3024 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.39 | 17.25 | 1924 | 4141 | 0.4646 | 0.8152 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.39 | 17.25 | 3 | 4141 | 0.0007 | -0.1985 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 46.39 | 17.25 | 2064 | 4141 | 0.4984 | 0.8314 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.36 | 17.25 | 1 | 4390 | 0.0002 | -0.2998 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.36 | 17.25 | 2049 | 4390 | 0.4667 | 0.8181 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.36 | 17.25 | 3 | 4390 | 0.0007 | -0.1966 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 48.36 | 17.25 | 2188 | 4390 | 0.4984 | 0.8331 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.33 | 17.25 | 1 | 4651 | 0.0002 | -0.2972 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.33 | 17.25 | 2168 | 4651 | 0.4661 | 0.8196 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.33 | 17.25 | 7 | 4651 | 0.0015 | -0.1057 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 50.33 | 17.25 | 2327 | 4651 | 0.5003 | 0.8356 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.30 | 17.25 | 1 | 4798 | 0.0002 | -0.2958 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.30 | 17.25 | 2337 | 4798 | 0.4870 | 0.8304 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.30 | 17.25 | 7 | 4798 | 0.0015 | -0.1051 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 52.30 | 17.25 | 2410 | 4798 | 0.5022 | 0.8374 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.27 | 17.25 | 1 | 4884 | 0.0002 | -0.2951 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.27 | 17.25 | 2441 | 4884 | 0.4998 | 0.8368 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.27 | 17.25 | 12 | 4884 | 0.0025 | -0.0436 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 54.27 | 17.25 | 2593 | 4884 | 0.5309 | 0.8504 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.24 | 17.25 | 1 | 4929 | 0.0002 | -0.2947 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.24 | 17.25 | 2544 | 4929 | 0.5161 | 0.8443 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.24 | 17.25 | 11 | 4929 | 0.0022 | -0.0537 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 56.24 | 17.25 | 2720 | 4929 | 0.5518 | 0.8594 | MN20160310_N02 | L16 |